Table 3.
Model 1 |
Model 2 |
Model 3 |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
(mean of values) |
(SD of values) |
(Subject-specific baseline values) |
(Subject specific rate of changes) |
|||||||||
Variable | HR/OR | 95% CI | p value | HR/OR | 95% CI | p value | HR/OR | 95% CI | p value | HR/OR | 95% CI | p value |
Death up to 3 months (n = 241) | ||||||||||||
Glucose (mg/dL) (N = 1269) | 1.010 | 1.007–1.013 | <0.001 | 1.005 | 0.999–1.011 | 0.100 | 1.011 | 1.008–1.015 | <0.001 | 1.043 | 1.008–1.080 | 0.017 |
SBP (mm Hg) (N = 1214) | 1.009 | 0.998–1.021 | 0.111 | 1.042 | 1.020–1.063 | <0.001 | 1.004 | 0.994–1.015 | 0.380 | 0.944 | 0.872–1.023 | 0.158 |
DBP (mm Hg) (N = 1212) | 0.987 | 0.964–1.011 | 0.289 | 1.027 | 0.990–1.065 | 0.151 | 0.993 | 0.972–1.015 | 0.548 | 0.842 | 0.695–1.021 | 0.081 |
Temperature (°C) (N = 1246) | 1.045 | 1.001–1.091 | 0.045 | 0.987 | 0.938–1.038 | 0.611 | 3.387 | 2.597–4.418 | <0.001 | 1.914* | 1.712–2.141 | <0.001 |
Poor functional outcome at 3 months (n = 668) | ||||||||||||
Glucose (mg/dL) (N = 1269) | 1.003 | 0.998–1.008 | 0.219 | 1.006 | 0.997–1.016 | 0.196 | 1.004 | 0.998–1.010 | 0.190 | 1.046 | 0.982–1.115 | 0.161 |
SBP (mm Hg) (N = 1214) | 1.003 | 0.992–1.014 | 0.573 | 1.013 | 0.987–1.040 | 0.322 | 1.007 | 0.995–1.020 | 0.259 | 1.156 | 1.047–1.277 | 0.004 |
DBP (mm Hg) (N = 1212) | 1.004 | 0.981–1.027 | 0.750 | 0.978 | 0.935–1.024 | 0.345 | 1.011 | 0.984–1.040 | 0.424 | 1.515 | 1.168–1.965 | 0.002 |
Temperature (oC) (N = 1246) | 1.728 | 1.188–2.51 | 0.004 | 1.349 | 0.578–3.15 | 0.489 | 1.775 | 1.137–2.772 | 0.012 | 1.336* | 1.036–1.722 | 0.026 |
SD: standard deviation.
Adjusted for baseline parameters: age, gender, NIHSS, eGFR, stroke subtype, history of hypertension, diabetes, smoking, dyslipidaemia, coronary artery diseases, TIAs, atrial fibrillation and in-hospital treatment (aspirin, anticoagulation, thrombolysis). Poor functional outcome, mRS > 2..
*Per 0.1°C change.